Division of Pulmonary and Critical Care Medicine, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, United States; NewYork-Presbyterian Hospital, Weill Cornell Medicine, New York, NY, United States.
NewYork-Presbyterian Hospital, Weill Cornell Medicine, New York, NY, United States; Division of Nephrology and Hypertension, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, New York, NY, United States.
Prog Mol Biol Transl Sci. 2020;172:135-156. doi: 10.1016/bs.pmbts.2020.02.001. Epub 2020 Mar 12.
The development of chronic lung disease occurs as a consequence of multiple cellular events that involve an initial insult which often leads to the development of chronic inflammation, and the dysregulation of cellular proliferation and cell death mechanisms. Multiple cell types in the lung are key to the respiratory and protective/barrier functions necessary to manage the chronic exposures to environmental, mechanical, and oxidative stressors. Autophagy is essential to lung development and homeostasis, as well as the prevention and development of disease. The cellular process involves the collection and removal of unwanted organelles and proteins through lysosomal degradation. In recent years, investigations have addressed the roles of autophagy and selective autophagy in numerous chronic lung diseases. Here, we highlight recent advances on the role of autophagy in the pathogenesis of asthma, chronic obstructive pulmonary disease and emphysema, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.
慢性肺病的发展是多种细胞事件的结果,这些事件涉及初始损伤,通常导致慢性炎症的发展,以及细胞增殖和细胞死亡机制的失调。肺中的多种细胞类型是管理对环境、机械和氧化应激因素的慢性暴露所必需的呼吸和保护/屏障功能的关键。自噬对于肺的发育和稳态,以及疾病的预防和发展都是必不可少的。这一细胞过程涉及通过溶酶体降解来收集和去除不需要的细胞器和蛋白质。近年来,研究已经探讨了自噬和选择性自噬在许多慢性肺病中的作用。在这里,我们重点介绍了自噬在哮喘、慢性阻塞性肺疾病和肺气肿、肺动脉高压以及特发性肺纤维化发病机制中的作用的最新进展。